Product Code: GVR-4-68040-126-5
Endoscopic Ultrasound Market Growth & Trends:
The global endoscopic ultrasound market size is anticipated to reach USD 2.27 billion by 2030, registering a CAGR of 6.72% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The increasing prevalence of various chronic disorders, such as colorectal cancer, and rectum cancer, rapid technological advancements, rising healthcare spending, and a rise in the geriatric population, are key contributors to the market growth. Advancements in endoscopic ultrasound (EUS) technology, such as improved endoscope systems and advanced ultrasound processor designs by various key manufacturers through different strategic initiatives, will further drive market growth.
For instance, in February 2023, FUJIFILM India Private Limited introduced the compact ultrasonic probe system PB2020-M2. This ultrasonic probe enables actual ultrasound imaging of peripheral lung lesions for a more effective evaluation. This compact, lightweight device offers high-quality ultrasonic images. In addition, key companies are launching new products to expand their endoscopy solutions portfolios. For instance, in January 2023, FUJIFILM India Private Limited launched ClutchCutter and FushKnife. These factors are expected to propel the market growth during the forecast period.
A rise in demand for minimally invasive procedures like EUS as they offer a faster recovery rate and minimize post-operative complications compared to traditional surgeries will support market growth. In addition, collaboration between medical device companies and healthcare institutions for R&D of EUS technologies further stimulates market growth. For instance, in September 2023, Fujifilm India formed a strategic partnership with the Yashoda Group of Hospitals. To improve patient care standards across the nation, this strategic alliance will support training and clinical research projects in collaboration with all Yashoda Group sites.
Endoscopic Ultrasound Market Report Highlights:
- The endoscope product segment dominated the market in 2022 with the largest share owing to the increased preference for minimally invasive surgical techniques and the prevalence of cancer & respiratory conditions
- The lung cancer application segment dominated the market in 2022 owing to the globally increasing air pollution and prevalence of chronic obstructive pulmonary disease (COPD)
- The hospitals segment held the largest market share in 2022 owing to favorable insurance coverage and reimbursement policies for EUS procedures in hospitals
- North America dominated the market with the highest revenue share in 2022 owing to the high incidence rate of gastrointestinal disease in this region and the highly developed healthcare infrastructure that supports the widespread adoption of advanced medical technologies like EUS
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. End - use
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. End - user outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Endoscopic Ultrasound Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing prevalence of gastrointestinal cancer
- 3.2.1.2. Growing geriatric population
- 3.2.1.3. Rapid technological advancements
- 3.2.1.4. Rise in demand for minimally invasive procedures
- 3.2.2. Market restraint analysis
- 3.2.2.1. Complications associated with endoscopic ultrasound imaging
- 3.2.3. Market opportunity analysis
- 3.3. Endoscopic Ultrasound Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.3. Covid - 19 Impact Analysis
Chapter 4. Endoscopic Ultrasound Market: Product Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Endoscope
- 4.1.2. Ultrasound Probe
- 4.1.3. Needle
- 4.1.4. Accessories
- 4.1.5. Ultrasonic Processors
- 4.2. Product Market Share, 2018 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Surgical Refractor Market by Product Outlook
- 4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
- 4.5.1. Endoscope
- 4.5.1.1. Endoscope market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.2. Ultrasound Probe
- 4.5.2.1. Ultrasound probe market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.3. Needle
- 4.5.3.1. Needle market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.4. Accessories
- 4.5.4.1. Accessories market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.5. Ultrasound Processors
- 4.5.5.1. Ultrasound processors market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Endoscopic Ultrasound Market: Application Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Gastrointestinal Cancer
- 5.1.2. Lung Cancer
- 5.1.3. Pancreaticobiliary Disease
- 5.1.4. Others
- 5.2. Application Market Share, 2018 & 2030
- 5.3. Segment Dashboard
- 5.4. Global Endoscopic Ultrasound Market by Application Outlook
- 5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
- 5.5.1. Gastrointestinal Cancer
- 5.5.1.1. Gastrointestinal cancer market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.2. Lung Cancer
- 5.5.2.1. Lung cancer market estimates and forecast 2018 to 2030 (USD Million
- 5.5.3. Pancreaticobiliary Disease
- 5.5.3.1. Pancreaticobiliary Disease market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.4. Others
- 5.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Endoscopic Ultrasound: End Use Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.1.1. Hospitals
- 6.1.2. Ambulatory Surgical Centers
- 6.1.3. Others
- 6.2. End Use Market Share, 2018 & 2030
- 6.3. Segment Dashboard
- 6.4. Global Endoscopic Ultrasound Market by End Use Outlook
- 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5.1. Hospitals
- 6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
- 6.5.2. Ambulatory Surgical Centers
- 6.5.2.1. Ambulatory surgical centers market estimates and forecast 2018 to 2030 (USD Million)
- 6.5.3. Others
- 6.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Endoscopic Ultrasound Market: Regional Estimates & Trend Analysis
- 7.1. Regional market share analysis, 2022 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Regional Market Share and Leading Players, 2022
- 7.4.1. North America
- 7.4.2. Europe
- 7.4.3. Asia Pacific
- 7.4.4. Latin America
- 7.4.5. Middle East and Africa
- 7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
- 7.6. North America
- 7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.6.2. U.S.
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory framework
- 7.6.2.4. Reimbursement scenario
- 7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
- 7.6.3. Canada
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory framework
- 7.6.3.4. Reimbursement scenario
- 7.6.3.5. Canada market estimates and forecasts, 2018 - 2030
- 7.7. Europe
- 7.7.1. UK
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Competitive Scenario
- 7.7.1.3. Regulatory framework
- 7.7.1.4. Reimbursement scenario
- 7.7.1.5. UK market estimates and forecasts, 2018 - 2030
- 7.7.2. Germany
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory framework
- 7.7.2.4. Reimbursement scenario
- 7.7.2.5. Germany market estimates and forecasts, 2018 - 2030
- 7.7.3. France
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory framework
- 7.7.3.4. Reimbursement scenario
- 7.7.3.5. France market estimates and forecasts, 2018 - 2030
- 7.7.4. Italy
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory framework
- 7.7.4.4. Reimbursement scenario
- 7.7.4.5. Italy market estimates and forecasts, 2018 - 2030
- 7.7.5. Spain
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory framework
- 7.7.5.4. Reimbursement scenario
- 7.7.5.5. Spain market estimates and forecasts, 2018 - 2030
- 7.7.6. Denmark
- 7.7.6.1. Key country dynamics
- 7.7.6.2. Competitive Scenario
- 7.7.6.3. Regulatory framework
- 7.7.6.4. Reimbursement scenario
- 7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
- 7.7.7. Sweden
- 7.7.7.1. Key country dynamics
- 7.7.7.2. Competitive Scenario
- 7.7.7.3. Regulatory framework
- 7.7.7.4. Reimbursement scenario
- 7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
- 7.7.8. Norway
- 7.7.8.1. Key country dynamics
- 7.7.8.2. Competitive Scenario
- 7.7.8.3. Regulatory framework
- 7.7.8.4. Reimbursement scenario
- 7.7.8.5. Norway market estimates and forecasts, 2018 - 2030
- 7.8. Asia Pacific
- 7.8.1. Japan
- 7.8.1.1. Key country dynamics
- 7.8.1.2. Competitive Scenario
- 7.8.1.3. Regulatory framework
- 7.8.1.4. Reimbursement scenario
- 7.8.1.5. Japan market estimates and forecasts, 2018 - 2030
- 7.8.2. India
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Competitive Scenario
- 7.8.2.3. Regulatory framework
- 7.8.2.4. Reimbursement scenario
- 7.8.2.5. India market estimates and forecasts, 2018 - 2030
- 7.8.3. China
- 7.8.3.1. Key country dynamics
- 7.8.3.2. Competitive Scenario
- 7.8.3.3. Regulatory framework
- 7.8.3.4. Reimbursement scenario
- 7.8.3.5. China market estimates and forecasts, 2018 - 2030
- 7.8.4. South Korea
- 7.8.4.1. Key country dynamics
- 7.8.4.2. Competitive Scenario
- 7.8.4.3. Regulatory framework
- 7.8.4.4. Reimbursement scenario
- 7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
- 7.8.5. Australia
- 7.8.5.1. Key country dynamics
- 7.8.5.2. Competitive Scenario
- 7.8.5.3. Regulatory framework
- 7.8.5.4. Reimbursement scenario
- 7.8.5.5. Australia market estimates and forecasts, 2018 - 2030
- 7.8.6. Thailand
- 7.8.6.1. Key country dynamics
- 7.8.6.2. Competitive Scenario
- 7.8.6.3. Regulatory framework
- 7.8.6.4. Reimbursement scenario
- 7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
- 7.9. Latin America
- 7.9.1. Brazil
- 7.9.1.1. Key country dynamics
- 7.9.1.2. Competitive Scenario
- 7.9.1.3. Regulatory framework
- 7.9.1.4. Reimbursement scenario
- 7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
- 7.9.2. Mexico
- 7.9.2.1. Key country dynamics
- 7.9.2.2. Competitive Scenario
- 7.9.2.3. Regulatory framework
- 7.9.2.4. Reimbursement scenario
- 7.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
- 7.9.3. Argentina
- 7.9.3.1. Key country dynamics
- 7.9.3.2. Competitive Scenario
- 7.9.3.3. Regulatory framework
- 7.9.3.4. Reimbursement scenario
- 7.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
- 7.10. MEA
- 7.10.1. South Africa
- 7.10.1.1. Key country dynamics
- 7.10.1.2. Competitive Scenario
- 7.10.1.3. Regulatory framework
- 7.10.1.4. Reimbursement scenario
- 7.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
- 7.10.2. Saudi Arabia
- 7.10.2.1. Key country dynamics
- 7.10.2.2. Competitive Scenario
- 7.10.2.3. Regulatory framework
- 7.10.2.4. Reimbursement scenario
- 7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
- 7.10.3. UAE
- 7.10.3.1. Key country dynamics
- 7.10.3.2. Competitive Scenario
- 7.10.3.3. Regulatory framework
- 7.10.3.4. Reimbursement scenario
- 7.10.3.5. UAE market estimates and forecasts, 2018 - 2030
- 7.10.4. Kuwait
- 7.10.4.1. Key country dynamics
- 7.10.4.2. Competitive Scenario
- 7.10.4.3. Regulatory framework
- 7.10.4.4. Reimbursement scenario
- 7.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2022
- 8.3.4. Boston Scientific Corporation
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Medtronic
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. ConMed
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Olympus Corporation
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Steris
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. SonoScape Medical Corp.
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. PENTEX Medical
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. FUJIFILM India Private Limited
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Product benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. Cook Medical
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Product benchmarking
- 8.3.12.4. Strategic initiatives